These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6180335)

  • 1. [Antineoplastic effect of 5-fluorocytosine and cytosine deaminase on brain tumor (author's transl)].
    Nishiyama T; Kawamura Y; Kawamoto K; Matsumura H; Yamamoto N; Ito T; Ohyama A; Katsuragi T; Sakai T
    Neurol Med Chir (Tokyo); 1982 May; 22(5):344-52. PubMed ID: 6180335
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules.
    Nishiyama T; Kawamura Y; Kawamoto K; Matsumura H; Yamamoto N; Ito T; Ohyama A; Katsuragi T; Sakai T
    Cancer Res; 1985 Apr; 45(4):1753-61. PubMed ID: 3978637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Gavelli A; Brossette N; Baqué P; Benchimol D; Bourgeon A; Staccini P; Rossi B
    J Natl Cancer Inst; 2000 Mar; 92(6):494-5. PubMed ID: 10716970
    [No Abstract]   [Full Text] [Related]  

  • 7. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.
    Nakamori M; Iwahashi M; Ueda K; Tsunoda T; Terasawa H; Hamada H; Yamaue H
    Jpn J Cancer Res; 2002 Jun; 93(6):706-15. PubMed ID: 12079520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.
    Stegman LD; Rehemtulla A; Hamstra DA; Rice DJ; Jonas SJ; Stout KL; Chenevert TL; Ross BD
    Gene Ther; 2000 Jun; 7(12):1005-10. PubMed ID: 10871748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha.
    Wang ZH; Zagzag D; Zeng B; Kolodny EH
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):847-58. PubMed ID: 10446809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.
    Liao WC; Chang WS; Wu FY
    J Natl Cancer Inst; 1999 Feb; 91(3):285-6. PubMed ID: 10037108
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxic effects of 5-fluorocytosine on melanoma cells transduced with cytosine deaminase gene.
    Lü H; Wu D; Wan Y; Gu B; Wang J
    J Environ Pathol Toxicol Oncol; 2000; 19(1-2):9-12. PubMed ID: 10905502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
    Kim JH; Kim JY; Kim SU; Cho KG
    Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine.
    Dong Y; Wen P; Manome Y; Parr M; Hirshowitz A; Chen L; Hirschowitz EA; Crystal R; Weichselbaum R; Kufe DW; Fine HA
    Hum Gene Ther; 1996 Apr; 7(6):713-20. PubMed ID: 8919593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon.
    Wang ZH; Samuels S; Gama Sosa MA; Kolodny EH
    J Neurooncol; 1998 Feb; 36(3):219-29. PubMed ID: 9524100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosine deaminase gene as a positive selection marker.
    Wei K; Huber BE
    J Biol Chem; 1996 Feb; 271(7):3812-6. PubMed ID: 8631998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
    Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.